NKG2D
![](https://www.catchall-kfo5010.com/wp-content/uploads/2022/04/p7.png)
Project-related publications
P1, P3, P6, P7, Z
The IL-7R antagonist Lusvertikimab reduces leukemic burden in xenograft-ALL via antibody-dependent cellular phagocytosis
P7
Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer
P3, P6, P7, Z
Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
P3, P4, P6, P7, Z